Connect with us

corporations

Cronos Group acquires CanAdelaar, the largest producer of adult-use cannabis in Europe, and enters the regulated market in the Netherlands.

Published

em

Listen to this article
Reading Time: 2 minutes

Canadian cannabis producer Cronos Group has announced an agreement to acquire a full stake in CanAdelaar BV, the largest adult-use cannabis company operating under the regulated program in the Netherlands. The initial transaction value is €57,5 million ($67 million), with potential increases through additional payments dependent on the company's financial performance in 2026 and 2027.

CanAdelaar is one of ten licensed producers in the Wietexperiment, the pilot program that regulates the supply of cannabis to participating coffeeshops. The company operates a 50,000-square-meter greenhouse in Voorne aan Zee and is responsible for supplying virtually all 72 coffeeshops involved in the program.

The portfolio includes flowers, pre-rolled cigarettes, hashish, and edibles, positioning CanAdelaar as the only large-scale supplier within the Dutch model.

In financial terms, the company recorded revenues exceeding $47 million and an EBITDA of $28 million in the last twelve months, a significant increase compared to the results for 2024.

Cronos' European strategy

With this acquisition, Cronos reinforces its international expansion strategy, integrating its research in genetics and product development into a European market that, although limited in the number of municipalities covered, represents the only regulated program for cannabis for adult use in operation on the continent.

Em releaseThe company emphasizes that CanAdelaar offers an "immediate platform" to introduce its portfolio to the Dutch market, while establishing a solid presence in one of the countries with the longest tradition of regulated cannabis consumption and sale.

“The acquisition of CanAdelaar is a financially attractive and highly strategic transaction that will establish a strategic presence in Europe and allow us to leverage our investments in borderless products,” said Mike Gorenstein, President and CEO of Cronos, in a press release.

“The Netherlands has a long cannabis tradition, and its coffeeshops are world-renowned for playing a pivotal role in the evolution of the legal cannabis industry. European expansion is an important area of ​​focus for us, and we were particularly intrigued by the fact that the Netherlands legislated and established a responsible and efficient adult-use cannabis market with the Wietexperiment. We are excited to work with the Dutch government, regulatory bodies, coffeeshops, adult consumers, and all stakeholders to make the Wietexperiment a continued success. The CanAdelaar management team has expanded the business quickly and efficiently, making them market leaders in Europe’s largest adult-use cannabis market.”

Pending approvals and potential for expansion.

The completion of the purchase is expected in early 2026, pending regulatory approvals in the Netherlands. The future of the operation could be influenced by a possible decision by the Dutch government to expand the Wietexperiment to more municipalities, which would significantly increase the reach of the legal market.

If the program is expanded, or evolves into a national model, Cronos could benefit from a privileged position in a European market undergoing transformation.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

More posts

With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.

Advertise with us!
Support independent journalism about cannabis.
Cannareporter needs you to continue informing.
If our work helps you stay up-to-date on cannabis policy, science, and industry, please consider supporting us with a monthly contribution on Patreon. Every contribution counts to keep the project free and independent.
Support us on Patreon
You can cancel your support at any time. Thank you for being part of our community.
Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertise with us!


Watch the Documentary "Patients" by Laura Ramos

Documentary Patients Laura Ramos help us grow

Mais recentes

National16 hours ago

Michael Sassano: "Approvals can be better streamlined and keep the same rigorous quality standards."

SOMAÍ Pharmaceuticals announced today that it has obtained three Marketing Authorizations (MAs) from Infarmed and...

International5 days ago

Spain: Supreme Court accepts pharmacists' appeal against the exclusion of community pharmacies from dispensing cannabis.

The Spanish Supreme Court has accepted the appeal filed by the Consejo General de Colegios de Farmacéuticos (CGCOF) last month...

National5 days ago

Infarmed grants three ACMs to SOMAÍ's first medicinal cannabis products in Portugal

Infarmed has granted Marketing Authorizations (MA) to three cannabis-based preparations and substances for the purpose of...

International5 days ago

France Extends Medical Cannabis Access Again as Full Access Bill Remains Stuck in Limbo

Thousands of French patients using medicinal cannabis will continue to receive their treatment for the foreseeable future, as...

International5 days ago

Brazil: Anvisa bans CBD purchased from Paraguay by the São Paulo Public Administration; Public Prosecutor's Office investigates.

The Brazilian National Health Surveillance Agency (Anvisa) seized a shipment of cannabidiol (CBD) products last November...

International5 days ago

Spain includes medicinal cannabis magistral preparations in the National Formulary

The Spanish Ministry of Health has officially approved the inclusion of standardized compounded cannabis (THC and CBD) solutions...

International5 days ago

Norway: AROD asks the International Criminal Court to consider drug prohibition a crime against humanity.

The Alliance for Rights-Oriented Drug Policies (AROD), a Norwegian organization advocating for the revision of drug laws, decided to send a...

Press Releases5 days ago

Relm Insurance and Prohibition Partners release cannabis risk report for emerging and high-growth industries.

Hamilton, Bermuda — January 15, 2026: Relm Insurance (Relm), a leading insurer focused on emerging industries, today launched...

Science6 days ago

Spain: Study reveals promising effects of CBD (cannabidiol) in controlling alcoholism.

An investigation by the Spanish National Research Council (CSIC) demonstrates that cannabidiol (CBD) and other components of...

National6 days ago

Joana de Almeida Teixeira succeeds João Goulão as president of ICAD.

The Institute for Addictive Behaviors and Dependencies (ICAD) announced this week its new Board of Directors, which...